{"title":"Early diagnosis of depressive symptoms as part of the comprehensive management of breast cancer patients.","authors":"Macarena Teja, Abrahams Ocanto, Felipe Couñago","doi":"10.5306/wjco.v16.i8.106627","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer is the most common cancer in women worldwide. A high percentage of these patients may have depressive symptoms and an early detection is crucial as part of a comprehensive management of the disease. Mao <i>et al</i> recently conducted a study constructing a depression risk predictive model in young and middle-aged breast cancer patients. Four questionnaires (a general one, Patient Health Questionnaire-9, Perceived Social Support From Family Scale and International Physical Activity Questionnaire) and the Visual Analogue Scale were used to examine the correlation between different variables and depressive symptoms. The constructed predictive model showed strong predictive capability with an area under the receiver operating characteristic curve of 0.852 and high sensitivity and specificity values. However, the screening depression tools and questionnaires to assess social support or physical activity are not originally designed for oncological patients and further investigation to corroborate their applicability in this context is relevant. The cross-sectional design of the study prevents establishing clear causal relationships between the identified risk factors and depression. Besides, the study includes only a sample of Chinese patients and the applicability in a different sociocultural context is uncertain. Further investigation is crucial to corroborate the results in larger samples and different contexts.</p>","PeriodicalId":23802,"journal":{"name":"World journal of clinical oncology","volume":"16 8","pages":"106627"},"PeriodicalIF":3.2000,"publicationDate":"2025-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12400244/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5306/wjco.v16.i8.106627","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Breast cancer is the most common cancer in women worldwide. A high percentage of these patients may have depressive symptoms and an early detection is crucial as part of a comprehensive management of the disease. Mao et al recently conducted a study constructing a depression risk predictive model in young and middle-aged breast cancer patients. Four questionnaires (a general one, Patient Health Questionnaire-9, Perceived Social Support From Family Scale and International Physical Activity Questionnaire) and the Visual Analogue Scale were used to examine the correlation between different variables and depressive symptoms. The constructed predictive model showed strong predictive capability with an area under the receiver operating characteristic curve of 0.852 and high sensitivity and specificity values. However, the screening depression tools and questionnaires to assess social support or physical activity are not originally designed for oncological patients and further investigation to corroborate their applicability in this context is relevant. The cross-sectional design of the study prevents establishing clear causal relationships between the identified risk factors and depression. Besides, the study includes only a sample of Chinese patients and the applicability in a different sociocultural context is uncertain. Further investigation is crucial to corroborate the results in larger samples and different contexts.
期刊介绍:
The WJCO is a high-quality, peer reviewed, open-access journal. The primary task of WJCO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of oncology. In order to promote productive academic communication, the peer review process for the WJCO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in oncology. Scope: Art of Oncology, Biology of Neoplasia, Breast Cancer, Cancer Prevention and Control, Cancer-Related Complications, Diagnosis in Oncology, Gastrointestinal Cancer, Genetic Testing For Cancer, Gynecologic Cancer, Head and Neck Cancer, Hematologic Malignancy, Lung Cancer, Melanoma, Molecular Oncology, Neurooncology, Palliative and Supportive Care, Pediatric Oncology, Surgical Oncology, Translational Oncology, and Urologic Oncology.